Literature DB >> 1191603

Metabolism of prostaglandins within the pregnant uterus.

M J Keirse, A C Turnbull.   

Abstract

The metabolism of E and F prostaglandins has been studied in both fetal and maternal tissues obtained from the pregnant human uterus. Both 15-hydroxyprostaglandin dehydrogenase and 13,14-prostaglandin reductase are shown to be widely distributed in these tissues. Comparison of the levels of enzyme activity in different tissues demonstrates that the greatest metabolism of prostaglandins takes place in the membranes and placenta and that there is much less in the myometrium and the decidua. The lowest enzyme activity was found in the umbilical cord, and no metabolism could be demonstrated in amniotic fluid or in umbilical venous blood. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191603     DOI: 10.1111/j.1471-0528.1975.tb00593.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Maternal and fetal intrauterine tissue crosstalk promotes proinflammatory amplification and uterine transition†.

Authors:  Kelycia B Leimert; Angela Messer; Theora Gray; Xin Fang; Sylvain Chemtob; David M Olson
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

2.  Despite a massive increase in cortisol secretion in women during parturition, there is an equally massive increase in prostaglandin synthesis. A paradox?

Authors:  M L Casey; P C MacDonald; M D Mitchell
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

3.  Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation.

Authors:  Robert J Phillips; Michel A Fortier; Andrés López Bernal
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-22       Impact factor: 3.007

4.  Prostaglandins in biofluids in pregnancy and labour: A systematic review.

Authors:  Eilidh M Wood; Kylie K Hornaday; Donna M Slater
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.